Differential expression of insulin-like growth factor binding proteins in human non-small cell lung cancer cell lines
Gabriele Jaques(Netherlands Comprehensive Cancer Organisation), K. Havemann(Philipps University of Marburg), Ulrich Kaiser(University of Applied Sciences Landshut), Paul Kiefer(The Honourable Society of Lincoln's Inn), Hans J Schöneberger(Philipps University of Marburg), B. Wegmann(Philipps University of Marburg), Detlef Brandscheid(Stadtkrankenhaus Schwabach)
Cited by 17
Related Papers
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
|Annals of Oncology|2006|280
Multiple roles for FGF-3 during cranial neural development in the chicken
|Development|1995|176